Frequency, Antimicrobial Susceptibility, and Molecular Characterization of Carbapenem-Resistant Enterobacterales Stratified by United States Census Divisions: Results From the INFORM Program (2018–2022)
Aztreonam-avibactam showed potent activity against CRE, including MBL producers. Resistance to ceftazidime-avibactam and meropenem-vaborbactam was observed among CRE because of increasing occurrence of MBL-producing isolates.
Authors
- John H. Kimbrough (ORCID: https://orcid.org/0000-0002-0457-1543)
- Timothy B Doyle (ORCID: https://orcid.org/0000-0002-1083-8742)
- Marisa Winkler (ORCID: https://orcid.org/0000-0002-9785-5034)
- Hélio S. Sader (ORCID: https://orcid.org/0000-0001-7022-6644)
- Mariana Castanheira
Institutions
- JMI Laboratories (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2025-03-27
- DOI
- https://doi.org/10.1093/ofid/ofaf005
- Citations
- 7
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 4.14
Funders
- AbbVie Canada